73/100BProcter & Gamble Company stock forecast 2027–2031What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Procter & Gamble Company is 166.78, 0.8% above the current price of 165.39. Their targets range from 149.00 to 190.00.
Of the 17 firms that rated Procter & Gamble Company in the past 12 months, 11 rate it buy or strong buy, 6 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 149.00 to 190.00, with an average of 166.78.
| Buy | 11 | |
| Hold | 6 | |
| Sell | 0 |
12-month price target
| Highest target | 190.00 |
| Average target | 166.78 |
| Lowest target | 149.00 |
| Current price | 165.39 |
Procter & Gamble Company price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Procter & Gamble Company price target and rating?
How analysts rate Procter & Gamble Company, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
11 of 17 firms rate it buy now, against 11 of 17 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Procter & Gamble Company analyst upgrades, downgrades and price targets
The latest rating change came on 23 October 2026, when Freedom Broker upgraded Procter & Gamble Company from Hold to Buy. The most recent new target came from Piper Sandler on 26 October 2026: 167.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 26 Oct 2026 | Piper Sandler Michael Lavery | Reiterated · Neutral | 142.00 → 167.00 | +17.6% | 161.02 |
| 26 Oct 2026 | Barclays | Reiterated · Equal Weight | 152.00 → 165.00 | +8.6% | 161.02 |
| 23 Oct 2026 | UBS | Reiterated · Buy | 166.00 → 190.00 | +14.5% | 161.64 |
| 23 Oct 2026 | UBS | — | 172.00 → 166.00 | -3.5% | 161.80 |
| 23 Oct 2026 | RBC Capital Nik Modi | Reiterated · Outperform | 166.00 → 169.00 | +1.8% | 165.59 |
| 23 Oct 2026 | Morgan Stanley | Reiterated · Overweight | 175.00 → 185.00 | +5.7% | 165.59 |
| 23 Oct 2026 | Freedom Broker | Upgraded · Hold → Buy | — | — | — |
| 22 Oct 2026 | Goldman Sachs | — | 161.00 | — | 165.59 |
| 6 Oct 2026 | RBC Capital Nik Modi | Reiterated · Outperform | 167.00 → 166.00 | -0.6% | 147.37 |
| 6 Oct 2026 | Evercore ISI | Upgraded · In Line → Outperform | 162.00 → 166.00 | +2.5% | 145.94 |
| 24 Aug 2026 | Bernstein Cristian Rios | — | 156.00 → 149.00 | -4.5% | 146.25 |
| 7 Aug 2026 | Argus Research | Downgraded · Buy → Hold | — | — | — |
| 30 Jul 2026 | HSBC Diego Serrano | Downgraded · Buy → Hold | 142.00 → 149.00 | +4.9% | 146.15 |
| 29 Jul 2026 | HSBC | — | 142.00 | — | 146.15 |
| 21 Jul 2026 | Barclays | Reiterated · Equal Weight | 146.00 → 152.00 | +4.1% | 149.14 |
| 11 Jun 2026 | Bernstein | — | 156.00 | — | 148.32 |
| 27 Apr 2026 | UBS | Reiterated · Buy | 170.00 → 172.00 | +1.2% | 148.47 |
| 27 Apr 2026 | Deutsche Bank Steve Powers | — | 163.00 | — | 148.63 |
| 27 Apr 2026 | Evercore ISI Robert Ottenstein | Reiterated · In Line | 162.00 | — | 148.11 |
| 27 Apr 2026 | Wells Fargo | Reiterated · Overweight | 177.00 → 164.00 | -7.3% | 148.11 |
| 14 Apr 2026 | Barclays | Reiterated · Equal Weight | 155.00 → 146.00 | -5.8% | 143.86 |
| 9 Apr 2026 | RBC Capital | — | 167.00 | — | 146.66 |
| 8 Apr 2026 | Piper Sandler | Reiterated · Neutral | 150.00 → 142.00 | -5.3% | 144.90 |
| 17 Feb 2026 | Wells Fargo | — | 165.00 → 177.00 | +7.3% | 160.07 |
| 27 Jan 2026 | TD Cowen | Downgraded · Buy → Hold | — | — | — |
| 23 Jan 2026 | UBS | Reiterated · Buy | 161.00 → 170.00 | +5.6% | 151.06 |
| 23 Jan 2026 | Wells Fargo Chris Carey | Reiterated · Overweight | 158.00 → 165.00 | +4.4% | 149.93 |
| 23 Jan 2026 | JP Morgan | Upgraded · Neutral → Overweight | — | — | — |
| 16 Jan 2026 | Barclays Lauren Lieberman | — | 151.00 → 155.00 | +2.6% | 144.37 |
| 14 Jan 2026 | UBS Peter Grom | Reiterated · Buy | 176.00 → 161.00 | -8.5% | 146.54 |
| 7 Jan 2026 | Piper Sandler | — | 150.00 | — | 139.91 |
| 5 Jan 2026 | Wells Fargo | Reiterated · Overweight | 158.00 | — | 140.04 |
| 17 Dec 2025 | Jefferies | Upgraded · Hold → Buy | — | — | — |
| 16 Dec 2025 | Jefferies | — | 179.00 | — | 145.21 |
| 8 Dec 2025 | Barclays | — | 153.00 → 151.00 | -1.3% | 143.45 |
Procter & Gamble Company EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Procter & Gamble Company's EPS to grow 5.9% a year until 2029, about as fast as over the last 5 years (3.8% a year) and the last 3 years (3.9%).
Analysts expect Procter & Gamble Company's revenue to grow 3.4% a year until 2029, about as fast as over the last 5 years (2.7% a year) and the last 3 years (2.0%).
Revenue
EPS
Does Procter & Gamble Company beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 3.5% off the result, either way, and their revenue estimate 1.2%, over the last 12 quarters.
- EPS beats
- 104 / 136
- Revenue beats
- 93 / 120
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +3.4%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 22 Oct 2026 | 1.88 | 2.00 | +6.4% | 22.80B | 23.28B | +2.1% |
| Q4 FY2026 | 29 Jul 2026 | 1.41 | 1.43 | +1.4% | 21.38B | 21.20B | -0.8% |
| Q3 FY2026 | 24 Apr 2026 | 1.56 | 1.59 | +1.9% | 20.53B | 21.24B | +3.4% |
| Q2 FY2026 | 22 Jan 2026 | 1.86 | 1.88 | +1.1% | 22.30B | 22.21B | -0.4% |
| Q1 FY2026 | 24 Oct 2025 | 1.90 | 1.99 | +4.7% | 22.18B | 22.39B | +0.9% |
| Q4 FY2025 | 29 Jul 2025 | 1.42 | 1.48 | +4.2% | 20.84B | 20.89B | +0.2% |
| Q3 FY2025 | 24 Apr 2025 | 1.52 | 1.54 | +1.3% | 20.15B | 19.78B | -1.9% |
| Q2 FY2025 | 22 Jan 2025 | 1.89 | 1.88 | -0.5% | 21.58B | 21.88B | +1.4% |
| Q1 FY2025 | 18 Oct 2024 | 1.90 | 1.93 | +1.6% | 21.99B | 21.74B | -1.1% |
| Q4 FY2024 | 30 Jul 2024 | 1.37 | 1.40 | +2.2% | 20.72B | 20.53B | -0.9% |
| Q3 FY2024 | 19 Apr 2024 | 1.41 | 1.52 | +7.8% | 20.43B | 20.20B | -1.2% |
| Q2 FY2024 | 23 Jan 2024 | 1.70 | 1.84 | +8.2% | 21.47B | 21.44B | -0.2% |
Procter & Gamble Company stock price 2027–2031: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Procter & Gamble Company's earnings keep growing at the 4.5% a year analysts expect to FY2029, it would earn about 8.57 a share in FY2031. At the P/E it has traded at over the last five years (21.7 to 26.3) that is 186.21 to 225.69 a share, or 207.73 at its average P/E of 24.2. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2027 | 6.98 | 151.55 | 169.06 | 183.68 |
| FY2028 | 7.40 | 160.86 | 179.45 | 194.97 |
| FY2029 | 7.85 | 170.64 | 190.35 | 206.81 |
| FY2030 (extrapolated) | 8.21 | 178.26 | 198.85 | 216.05 |
| FY2031 (extrapolated) | 8.57 | 186.21 | 207.73 | 225.69 |
Each year's EPS is the analysts' consensus to FY2029; the years after grow 4.5% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (21.7, 24.2, 26.3).
Is Procter & Gamble Company stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Procter & Gamble Company's P/E of 24.5 is around the middle of its 5-year range (19.6 to 30.2, median 24.8). It is in line with its own history. Buyers pay less for each point of growth than usual: a PEG of 4.2 on expected growth against 6.6 on its median P/E and past five years' growth. At its usual P/E (24.8 × EPS of 6.75), Procter & Gamble Company's fair value is 167.60, close to the price of 165.39. Its forward P/E, on the consensus for FY2027, is 23.7.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (19.6 and 30.2). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 24.50
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 24.83
- Five-year P/E range
- 19.6 – 30.2
- Forward P/E (FY2027)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 23.71
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 5.49
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +0.8%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 194.93146Price 99.09244 | +96.7% | |
| 42.225 | 82.9546Price 42.23165 | +96.4% | |
| 186.680 | 360.82271Price 186.68451 | +93.3% | |
| 213.670 | 405.57304Price 213.67507 | +89.8% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 160.650 | 300.09225Price 160.65375 | +86.8% | |
| 165.860 | 308.95212Price 165.86442 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.